As of 2026-09-20, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -2,168.80 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Evelo Biosciences Inc is -216,880,500,000.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 216,880,500,000.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2,168.80 - -2,168.80 | -2,168.80 | -216,880,500,000.00% |
| P/E | (41.81) - (89.44) | (75.26) | -7525754993.9% |
| DDM - Stable | (0.00) - (0.00) | (0.00) | -4678.6% |
| DDM - Multi | (0.00) - (0.00) | (0.00) | -22254.7% |
| Market Cap (mil) | 0.00 |
| Beta | 51.61 |
| Outstanding shares (mil) | 18.98 |
| Enterprise Value (mil) | 16.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 8,106,907.00% |
| Cost of Debt | 5.00% |
| WACC | 8.51% |